caption a7 organism esbl compound camhb mic Search Results


caption a7 strain meropenem  (ATCC)
96
ATCC caption a7 strain meropenem
Fold change of reduction of <t> meropenem </t> MIC in combination over <t> meropenem </t> alone and ΣFICI values in CAMHB
Caption A7 Strain Meropenem, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 strain meropenem/product/ATCC
Average 96 stars, based on 1 article reviews
caption a7 strain meropenem - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
caption a7 organism esbl compound camhb mic  (ATCC)
99
ATCC caption a7 organism esbl compound camhb mic
MICs of tebipenem against selected bacterial pathogens a
Caption A7 Organism Esbl Compound Camhb Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/caption a7 organism esbl compound camhb mic/product/ATCC
Average 99 stars, based on 1 article reviews
caption a7 organism esbl compound camhb mic - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
mri system ge mr750 discovery siemens trio  (Siemens AG)
90
Siemens AG mri system ge mr750 discovery siemens trio
Subject demographics for the Centre for Addiction and Mental Health <t> (CAMH), </t> <t> Maryland Psychiatric Research Center </t> (MPRC) and Zucker Hillside Hospital (ZHH) sites. Severity of psychiatric symptoms was ascertained using the Brief Psychiatric Rating Scale (BPRS). Antipsychotic medication dose is provided in the chlorpromazine equivalent dose (mg/day). The severity of tobacco dependence was ascertained using the Fagerstrom Test for Nicotine Dependence (FTDN).
Mri System Ge Mr750 Discovery Siemens Trio, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mri system ge mr750 discovery siemens trio/product/Siemens AG
Average 90 stars, based on 1 article reviews
mri system ge mr750 discovery siemens trio - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
camhb  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute camhb
Subject demographics for the Centre for Addiction and Mental Health <t> (CAMH), </t> <t> Maryland Psychiatric Research Center </t> (MPRC) and Zucker Hillside Hospital (ZHH) sites. Severity of psychiatric symptoms was ascertained using the Brief Psychiatric Rating Scale (BPRS). Antipsychotic medication dose is provided in the chlorpromazine equivalent dose (mg/day). The severity of tobacco dependence was ascertained using the Fagerstrom Test for Nicotine Dependence (FTDN).
Camhb, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/camhb/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
camhb - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Fold change of reduction of meropenem MIC in combination over meropenem alone and ΣFICI values in CAMHB

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae

doi: 10.1128/AAC.01839-19

Figure Lengend Snippet: Fold change of reduction of meropenem MIC in combination over meropenem alone and ΣFICI values in CAMHB

Article Snippet: Fold change of reduction of meropenem MIC in combination over meropenem alone and ΣFICI values in CAMHB table ft1 table-wrap mode="anchored" t5 TABLE 3 caption a7 Strain Meropenem in combination with a : CIP LVX CS FOS NFT RIF TGC TOB FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI Carbapenem susceptible E. coli ATCC 25922 1 2 1.5 0.565 1 2 8 0.25 4 0.75 2 0.75 5 0.813 2 0.625 K. pneumoniae 595 2 0.563 2 0.625 1 2 2 0.75 2 1 32 0.516 1 2 2 0.625 E. cloacae CHD57 1 2 1 2 2 1 64 0.516 2 1 1 2 2 0.531 32 0.531 Median 1 2 1.5 0.625 1 2 8 0.516 2 1 2 0.75 2 0.813 2 0.625 Carbapenem resistant E. coli IR3 8 0.375 8 0.5 12 0.141 4 0.5 4 0.313 12 0.375 6 0.438 1 2 NRZ14408 4 0.75 3 0.625 8 0.625 10 0.407 8 0.625 3 0.875 8 0.625 1 2 BAA2469 2 1 12 0.407 12 0.157 24 0.297 4 0.75 8 0.265 8 0.625 1 2 K. pneumoniae BAA1705 1 2 1 2 17 0.766 20 0.328 1 2 20 0.578 2 1 16 0.563 BAA2146 1.5 0.75 1 2 5 0.813 4 0.5 1 2 6 0.438 16 0.188 1 2 E. cloacae BAA2468 2.5 0.75 2 0.438 4 0.344 2.5 0.75 1 2 3 0.563 4 0.75 1 2 Median 2.25 0.75 2.5 0.563 10 0.485 7 0.453 2.5 1.375 7 0.5 7 0.625 1 2 Open in a separate window a FC, fold change; CIP, ciprofloxacin; LVX, levofloxacin; CS, colistin sulfate; FOS, fosfomycin; NFT, nitrofurantoin; RIF, rifampin; TGC, tigecycline; TOB, tobramycin.

Techniques:

Fold change of reduction of meropenem MIC in combination over meropenem alone and ΣFICI values in AU

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae

doi: 10.1128/AAC.01839-19

Figure Lengend Snippet: Fold change of reduction of meropenem MIC in combination over meropenem alone and ΣFICI values in AU

Article Snippet: Fold change of reduction of meropenem MIC in combination over meropenem alone and ΣFICI values in CAMHB table ft1 table-wrap mode="anchored" t5 TABLE 3 caption a7 Strain Meropenem in combination with a : CIP LVX CS FOS NFT RIF TGC TOB FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI FC ΣFICI Carbapenem susceptible E. coli ATCC 25922 1 2 1.5 0.565 1 2 8 0.25 4 0.75 2 0.75 5 0.813 2 0.625 K. pneumoniae 595 2 0.563 2 0.625 1 2 2 0.75 2 1 32 0.516 1 2 2 0.625 E. cloacae CHD57 1 2 1 2 2 1 64 0.516 2 1 1 2 2 0.531 32 0.531 Median 1 2 1.5 0.625 1 2 8 0.516 2 1 2 0.75 2 0.813 2 0.625 Carbapenem resistant E. coli IR3 8 0.375 8 0.5 12 0.141 4 0.5 4 0.313 12 0.375 6 0.438 1 2 NRZ14408 4 0.75 3 0.625 8 0.625 10 0.407 8 0.625 3 0.875 8 0.625 1 2 BAA2469 2 1 12 0.407 12 0.157 24 0.297 4 0.75 8 0.265 8 0.625 1 2 K. pneumoniae BAA1705 1 2 1 2 17 0.766 20 0.328 1 2 20 0.578 2 1 16 0.563 BAA2146 1.5 0.75 1 2 5 0.813 4 0.5 1 2 6 0.438 16 0.188 1 2 E. cloacae BAA2468 2.5 0.75 2 0.438 4 0.344 2.5 0.75 1 2 3 0.563 4 0.75 1 2 Median 2.25 0.75 2.5 0.563 10 0.485 7 0.453 2.5 1.375 7 0.5 7 0.625 1 2 Open in a separate window a FC, fold change; CIP, ciprofloxacin; LVX, levofloxacin; CS, colistin sulfate; FOS, fosfomycin; NFT, nitrofurantoin; RIF, rifampin; TGC, tigecycline; TOB, tobramycin.

Techniques:

MICs of tebipenem against selected bacterial pathogens a

Journal: Antimicrobial Agents and Chemotherapy

Article Title: In Vitro and In Vivo Characterization of Tebipenem, an Oral Carbapenem

doi: 10.1128/AAC.02240-19

Figure Lengend Snippet: MICs of tebipenem against selected bacterial pathogens a

Article Snippet: Effect of varying the pH on antibacterial activity of tebipenem in media and pooled human urine table ft1 table-wrap mode="anchored" t5 TABLE 5 caption a7 Organism ESBL Compound CAMHB MIC (μg/ml) (fold vs CAMHB) a 50% human serum 10% human serum 50% mouse serum 10% mouse serum E. coli ATCC 25922 N Tebipenem 0.15 0.03 (2) 0.03 (2) 0.5 (32) 0.06 (4) Meropenem 0.015 0.03 (2) 0.03 (2) 0.03 (2) 0.03 (2) E. coli ATCC 35218 Y Tebipenem 0.15 0.03 (2) 0.03 (2) 0.5 (32) 0.03 (2) Meropenem 0.015 0.03 (2) 0.03 (2) 0.03 (2) 0.015 (0) K. pneumoniae ATCC 43816 N Tebipenem 0.03 0.06 (2) 0.03 (0) 1 (32) 0.06 (2) Meropenem 0.03 0.03 (0) 0.03 (0) 0.03 (0) 0.03 (0) K. pneumoniae ATCC 700603 Y Tebipenem 0.06 0.12 (2) 0.06 (0) 2 (32) 0.12 (2) Meropenem 0.03 0.06 (2) 0.03 (0) 0.12 (4) 0.03 (0) P. mirabilis ATCC 43071 N Tebipenem 0.12 0.25 (2) 0.25 (2) 2 (16) 0.25 (2) Meropenem 0.06 0.12 (2) 0.12 (2) 0.06 (0) 0.06 (0) P. mirabilis MMX 6343 Y Tebipenem 0.5 0.5 (0) 1 (2) 4 (8) 1 (2) Meropenem 0.12 0.12 (0) 0.12 (0) 0.25 (2) 0.5 (4) Open in a separate window a Bold indicates >4× differences from standard conditions (CAMHB minus serum).

Techniques:

Impact of inoculum on MICs of tebipenem and meropenem a

Journal: Antimicrobial Agents and Chemotherapy

Article Title: In Vitro and In Vivo Characterization of Tebipenem, an Oral Carbapenem

doi: 10.1128/AAC.02240-19

Figure Lengend Snippet: Impact of inoculum on MICs of tebipenem and meropenem a

Article Snippet: Effect of varying the pH on antibacterial activity of tebipenem in media and pooled human urine table ft1 table-wrap mode="anchored" t5 TABLE 5 caption a7 Organism ESBL Compound CAMHB MIC (μg/ml) (fold vs CAMHB) a 50% human serum 10% human serum 50% mouse serum 10% mouse serum E. coli ATCC 25922 N Tebipenem 0.15 0.03 (2) 0.03 (2) 0.5 (32) 0.06 (4) Meropenem 0.015 0.03 (2) 0.03 (2) 0.03 (2) 0.03 (2) E. coli ATCC 35218 Y Tebipenem 0.15 0.03 (2) 0.03 (2) 0.5 (32) 0.03 (2) Meropenem 0.015 0.03 (2) 0.03 (2) 0.03 (2) 0.015 (0) K. pneumoniae ATCC 43816 N Tebipenem 0.03 0.06 (2) 0.03 (0) 1 (32) 0.06 (2) Meropenem 0.03 0.03 (0) 0.03 (0) 0.03 (0) 0.03 (0) K. pneumoniae ATCC 700603 Y Tebipenem 0.06 0.12 (2) 0.06 (0) 2 (32) 0.12 (2) Meropenem 0.03 0.06 (2) 0.03 (0) 0.12 (4) 0.03 (0) P. mirabilis ATCC 43071 N Tebipenem 0.12 0.25 (2) 0.25 (2) 2 (16) 0.25 (2) Meropenem 0.06 0.12 (2) 0.12 (2) 0.06 (0) 0.06 (0) P. mirabilis MMX 6343 Y Tebipenem 0.5 0.5 (0) 1 (2) 4 (8) 1 (2) Meropenem 0.12 0.12 (0) 0.12 (0) 0.25 (2) 0.5 (4) Open in a separate window a Bold indicates >4× differences from standard conditions (CAMHB minus serum).

Techniques:

Impact of human, mouse serum on tebipenem, meropenem MIC

Journal: Antimicrobial Agents and Chemotherapy

Article Title: In Vitro and In Vivo Characterization of Tebipenem, an Oral Carbapenem

doi: 10.1128/AAC.02240-19

Figure Lengend Snippet: Impact of human, mouse serum on tebipenem, meropenem MIC

Article Snippet: Effect of varying the pH on antibacterial activity of tebipenem in media and pooled human urine table ft1 table-wrap mode="anchored" t5 TABLE 5 caption a7 Organism ESBL Compound CAMHB MIC (μg/ml) (fold vs CAMHB) a 50% human serum 10% human serum 50% mouse serum 10% mouse serum E. coli ATCC 25922 N Tebipenem 0.15 0.03 (2) 0.03 (2) 0.5 (32) 0.06 (4) Meropenem 0.015 0.03 (2) 0.03 (2) 0.03 (2) 0.03 (2) E. coli ATCC 35218 Y Tebipenem 0.15 0.03 (2) 0.03 (2) 0.5 (32) 0.03 (2) Meropenem 0.015 0.03 (2) 0.03 (2) 0.03 (2) 0.015 (0) K. pneumoniae ATCC 43816 N Tebipenem 0.03 0.06 (2) 0.03 (0) 1 (32) 0.06 (2) Meropenem 0.03 0.03 (0) 0.03 (0) 0.03 (0) 0.03 (0) K. pneumoniae ATCC 700603 Y Tebipenem 0.06 0.12 (2) 0.06 (0) 2 (32) 0.12 (2) Meropenem 0.03 0.06 (2) 0.03 (0) 0.12 (4) 0.03 (0) P. mirabilis ATCC 43071 N Tebipenem 0.12 0.25 (2) 0.25 (2) 2 (16) 0.25 (2) Meropenem 0.06 0.12 (2) 0.12 (2) 0.06 (0) 0.06 (0) P. mirabilis MMX 6343 Y Tebipenem 0.5 0.5 (0) 1 (2) 4 (8) 1 (2) Meropenem 0.12 0.12 (0) 0.12 (0) 0.25 (2) 0.5 (4) Open in a separate window a Bold indicates >4× differences from standard conditions (CAMHB minus serum).

Techniques:

Subject demographics for the Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites. Severity of psychiatric symptoms was ascertained using the Brief Psychiatric Rating Scale (BPRS). Antipsychotic medication dose is provided in the chlorpromazine equivalent dose (mg/day). The severity of tobacco dependence was ascertained using the Fagerstrom Test for Nicotine Dependence (FTDN).

Journal: Human brain mapping

Article Title: Integration of routine QA data into mega-analysis may improve quality and sensitivity of multi-site diffusion tensor imaging studies

doi: 10.1002/hbm.23900

Figure Lengend Snippet: Subject demographics for the Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites. Severity of psychiatric symptoms was ascertained using the Brief Psychiatric Rating Scale (BPRS). Antipsychotic medication dose is provided in the chlorpromazine equivalent dose (mg/day). The severity of tobacco dependence was ascertained using the Fagerstrom Test for Nicotine Dependence (FTDN).

Article Snippet: Details of the implementation of the protocol at each site are summarized in . table ft1 table-wrap mode="anchored" t5 caption a7 CAMH MPRC ZHH MRI system GE MR750 Discovery Siemens Trio GE HDx Year of Installation 2010 2011 2004 Head Coil 8-channel 12-channel 8-channel Acceleration Asset=2 GRAPPA=2 Asset=2 Echo Time (ms) 88 85 88 Repetition Time (ms) 8800 8800 17000 Flip Angle (degrees) 90/180/180 90/180 90/180/180 FOV (mm) 256 256 256 In-plane resolution (mm) 2.0×2.0 2.0×2.0 2.0×2.0 Slice Thickness (mm) 2.0 2.0 2.0 Number of Slices 66 66 66 Open in a separate window DTI sequence parameters for Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites.

Techniques:

DTI sequence parameters for Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites. Partial k-space acceleration techniques, Array Spatial Sensitivity Encoding Technique (Asset) and Generalized Autocalibrating Partially Parallel Acquisitions (GRAPPA) were used on GE and Siemens scanners, respectively, to reduce effective TE and TE by undersampling k-space along the phase encoding direction. A twice refocused spin-echo EPI sequence was used on the GE scanners to improve spatial distortions. A refocused mono-polar EPI sequence was used on the Siemens scanner to improve SNR.

Journal: Human brain mapping

Article Title: Integration of routine QA data into mega-analysis may improve quality and sensitivity of multi-site diffusion tensor imaging studies

doi: 10.1002/hbm.23900

Figure Lengend Snippet: DTI sequence parameters for Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites. Partial k-space acceleration techniques, Array Spatial Sensitivity Encoding Technique (Asset) and Generalized Autocalibrating Partially Parallel Acquisitions (GRAPPA) were used on GE and Siemens scanners, respectively, to reduce effective TE and TE by undersampling k-space along the phase encoding direction. A twice refocused spin-echo EPI sequence was used on the GE scanners to improve spatial distortions. A refocused mono-polar EPI sequence was used on the Siemens scanner to improve SNR.

Article Snippet: Details of the implementation of the protocol at each site are summarized in . table ft1 table-wrap mode="anchored" t5 caption a7 CAMH MPRC ZHH MRI system GE MR750 Discovery Siemens Trio GE HDx Year of Installation 2010 2011 2004 Head Coil 8-channel 12-channel 8-channel Acceleration Asset=2 GRAPPA=2 Asset=2 Echo Time (ms) 88 85 88 Repetition Time (ms) 8800 8800 17000 Flip Angle (degrees) 90/180/180 90/180 90/180/180 FOV (mm) 256 256 256 In-plane resolution (mm) 2.0×2.0 2.0×2.0 2.0×2.0 Slice Thickness (mm) 2.0 2.0 2.0 Number of Slices 66 66 66 Open in a separate window DTI sequence parameters for Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites.

Techniques: Sequencing

Factor analyses using principal component extraction and orthogonalization were performed on QA data collected at the three sites.

Journal: Human brain mapping

Article Title: Integration of routine QA data into mega-analysis may improve quality and sensitivity of multi-site diffusion tensor imaging studies

doi: 10.1002/hbm.23900

Figure Lengend Snippet: Factor analyses using principal component extraction and orthogonalization were performed on QA data collected at the three sites.

Article Snippet: Details of the implementation of the protocol at each site are summarized in . table ft1 table-wrap mode="anchored" t5 caption a7 CAMH MPRC ZHH MRI system GE MR750 Discovery Siemens Trio GE HDx Year of Installation 2010 2011 2004 Head Coil 8-channel 12-channel 8-channel Acceleration Asset=2 GRAPPA=2 Asset=2 Echo Time (ms) 88 85 88 Repetition Time (ms) 8800 8800 17000 Flip Angle (degrees) 90/180/180 90/180 90/180/180 FOV (mm) 256 256 256 In-plane resolution (mm) 2.0×2.0 2.0×2.0 2.0×2.0 Slice Thickness (mm) 2.0 2.0 2.0 Number of Slices 66 66 66 Open in a separate window DTI sequence parameters for Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites.

Techniques: Extraction

Pearson correlation coefficients between average FA values and two orthogonal QA factors and percent variance in average FA explained by two factors based on linear regression analysis.

Journal: Human brain mapping

Article Title: Integration of routine QA data into mega-analysis may improve quality and sensitivity of multi-site diffusion tensor imaging studies

doi: 10.1002/hbm.23900

Figure Lengend Snippet: Pearson correlation coefficients between average FA values and two orthogonal QA factors and percent variance in average FA explained by two factors based on linear regression analysis.

Article Snippet: Details of the implementation of the protocol at each site are summarized in . table ft1 table-wrap mode="anchored" t5 caption a7 CAMH MPRC ZHH MRI system GE MR750 Discovery Siemens Trio GE HDx Year of Installation 2010 2011 2004 Head Coil 8-channel 12-channel 8-channel Acceleration Asset=2 GRAPPA=2 Asset=2 Echo Time (ms) 88 85 88 Repetition Time (ms) 8800 8800 17000 Flip Angle (degrees) 90/180/180 90/180 90/180/180 FOV (mm) 256 256 256 In-plane resolution (mm) 2.0×2.0 2.0×2.0 2.0×2.0 Slice Thickness (mm) 2.0 2.0 2.0 Number of Slices 66 66 66 Open in a separate window DTI sequence parameters for Centre for Addiction and Mental Health (CAMH), Maryland Psychiatric Research Center (MPRC) and Zucker Hillside Hospital (ZHH) sites.

Techniques: